BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35644374)

  • 1. The hallmarks of aging in Ataxia-Telangiectasia.
    Aguado J; Gómez-Inclán C; Leeson HC; Lavin MF; Shiloh Y; Wolvetang EJ
    Ageing Res Rev; 2022 Aug; 79():101653. PubMed ID: 35644374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia-telangiectasia (A-T): An emerging dimension of premature ageing.
    Shiloh Y; Lederman HM
    Ageing Res Rev; 2017 Jan; 33():76-88. PubMed ID: 27181190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cerebellar degeneration in ataxia-telangiectasia: A case for genome instability.
    Shiloh Y
    DNA Repair (Amst); 2020 Nov; 95():102950. PubMed ID: 32871349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between DNA damage response and the central carbon metabolic network underlies selective vulnerability of Purkinje neurons in ataxia-telangiectasia.
    Sun JK; Wong GC; Chow KH
    J Neurochem; 2023 Aug; 166(4):654-677. PubMed ID: 37319113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress in ataxia telangiectasia.
    Watters DJ
    Redox Rep; 2003; 8(1):23-9. PubMed ID: 12631440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage.
    Barzilai A; Rotman G; Shiloh Y
    DNA Repair (Amst); 2002 Jan; 1(1):3-25. PubMed ID: 12509294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia telangiectasia syndrome: moonlighting ATM.
    Zaki-Dizaji M; Akrami SM; Abolhassani H; Rezaei N; Aghamohammadi A
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1155-1172. PubMed ID: 29034753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated replicative senescence of ataxia-telangiectasia skin fibroblasts is retained at physiologic oxygen levels, with unique and common transcriptional patterns.
    Haj M; Levon A; Frey Y; Hourvitz N; Campisi J; Tzfati Y; Elkon R; Ziv Y; Shiloh Y
    Aging Cell; 2023 Aug; 22(8):e13869. PubMed ID: 37254625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atm reactivation reverses ataxia telangiectasia phenotypes in vivo.
    Di Siena S; Campolo F; Gimmelli R; Di Pietro C; Marazziti D; Dolci S; Lenzi A; Nussenzweig A; Pellegrini M
    Cell Death Dis; 2018 Feb; 9(3):314. PubMed ID: 29472706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia.
    Sharma NK; Lebedeva M; Thomas T; Kovalenko OA; Stumpf JD; Shadel GS; Santos JH
    DNA Repair (Amst); 2014 Jan; 13():22-31. PubMed ID: 24342190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunction of cerebellar microglia in Ataxia-telangiectasia.
    Levi H; Bar E; Cohen-Adiv S; Sweitat S; Kanner S; Galron R; Mitiagin Y; Barzilai A
    Glia; 2022 Mar; 70(3):536-557. PubMed ID: 34854502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.
    Campbell A; Krupp B; Bushman J; Noble M; Pröschel C; Mayer-Pröschel M
    Hum Mol Genet; 2015 Nov; 24(22):6331-49. PubMed ID: 26310626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of DDX1 in the oxidative response of ataxia telangiectasia patient-derived fibroblasts.
    Garg M; Li L; Godbout R
    Redox Biol; 2024 Feb; 69():102988. PubMed ID: 38096740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrophy, oxidative switching and ultrastructural defects in skeletal muscle of the ataxia telangiectasia mouse model.
    Tassinari V; De Gennaro V; La Sala G; Marazziti D; Bolasco G; Aguanno S; De Angelis L; Naro F; Pellegrini M
    J Cell Sci; 2019 Mar; 132(5):. PubMed ID: 30745336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia.
    Lavin MF; Khanna KK
    Int J Radiat Biol; 1999 Oct; 75(10):1201-14. PubMed ID: 10549596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease severity in a mouse model of ataxia telangiectasia is modulated by the DNA damage checkpoint gene Hus1.
    Balmus G; Zhu M; Mukherjee S; Lyndaker AM; Hume KR; Lee J; Riccio ML; Reeves AP; Sutter NB; Noden DM; Peters RM; Weiss RS
    Hum Mol Genet; 2012 Aug; 21(15):3408-20. PubMed ID: 22575700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodegeneration in ataxia-telangiectasia: Multiple roles of ATM kinase in cellular homeostasis.
    Choy KR; Watters DJ
    Dev Dyn; 2018 Jan; 247(1):33-46. PubMed ID: 28543935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, a significant player of Ataxia-Telangiectasia pathogenesis?
    Zaki-Dizaji M; Akrami SM; Azizi G; Abolhassani H; Aghamohammadi A
    Inflamm Res; 2018 Jul; 67(7):559-570. PubMed ID: 29582093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel pathogenic variant in an Iranian Ataxia telangiectasia family revealed by next-generation sequencing followed by in silico analysis.
    Tabatabaiefar MA; Alipour P; Pourahmadiyan A; Fattahi N; Shariati L; Golchin N; Mohammadi-Asl J
    J Neurol Sci; 2017 Aug; 379():212-216. PubMed ID: 28716242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis.
    Taylor AM; Groom A; Byrd PJ
    DNA Repair (Amst); 2004; 3(8-9):1219-25. PubMed ID: 15279810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.